{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T20:05:30Z","timestamp":1695758730710},"reference-count":98,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.idc.2007.01.004","type":"journal-article","created":{"date-parts":[[2007,5,15]],"date-time":"2007-05-15T13:30:47Z","timestamp":1179235847000},"page":"133-148","source":"Crossref","is-referenced-by-count":6,"title":["Special Care Issues of Women Living with HIV-AIDS"],"prefix":"10.1016","volume":"21","author":[{"given":"Erna Milunka","family":"Kojic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Cu-Uvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2007.01.004_bib1","unstructured":"CDC. Cases of HIV infection and AIDS in the United States, 2004. Available at: http:\/\/www.cdc.gov\/hiv\/topics\/surveillance\/resources\/reports\/2004report. Accessed November 15, 2006."},{"key":"10.1016\/j.idc.2007.01.004_bib2","unstructured":"UNAIDS. Global coalition on women and AIDS. Available at: http:\/\/womenandaids.org. Accessed November 15, 2006."},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00002030-198802000-00008","article-title":"Genital ulceration as a risk factor for human immunodeficiency virus infection","volume":"2","author":"Greenblatt","year":"1988","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.idc.2007.01.004_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/infdis\/163.2.233","article-title":"Cofactors in male-female sexual transmission of human immunodeficiency virus type 1","volume":"163","author":"Plummer","year":"1991","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2007.01.004_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00007435-199219020-00001","article-title":"Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases","volume":"19","author":"Wasserheit","year":"1992","journal-title":"Sex Transm Dis"},{"issue":"5","key":"10.1016\/j.idc.2007.01.004_bib6","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1086\/313434","article-title":"Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group","volume":"29","author":"Cu-Uvin","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2007.01.004_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/505496","article-title":"Management of herpes simplex virus type 2 infection in HIV type 1-infected persons","volume":"43","author":"Strick","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2007.01.004_bib8","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1086\/317436","article-title":"Gynecologic infections in human immunodeficiency virus-infected women","volume":"31","author":"Sobel","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2007.01.004_bib9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/422755","article-title":"Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy","volume":"190","author":"Posavad","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2007.01.004_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/515621","article-title":"Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data","volume":"178","author":"Ioannidis","year":"1998","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2007.01.004_bib11","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1086\/322613","article-title":"Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract","volume":"33","author":"Cu-Uvin","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2007.01.004_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1067\/mob.2002.119776","article-title":"Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection","volume":"186","author":"Jamieson","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.idc.2007.01.004_bib14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnci\/91.3.226","article-title":"Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women","volume":"91","author":"Palefsky","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.idc.2007.01.004_bib15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM199711063371903","article-title":"Human papillomavirus infection in women infected with the human immunodeficiency virus","volume":"337","author":"Sun","year":"1997","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.idc.2007.01.004_bib16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jama.283.8.1031","article-title":"Incidence of cervical squamous intraepithelial lesions in HIV-infected women","volume":"283","author":"Ellerbrock","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00126334-199905010-00005","article-title":"Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group","volume":"21","author":"Massad","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"16","key":"10.1016\/j.idc.2007.01.004_bib18","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/00002030-200111090-00011","article-title":"The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women","volume":"15","author":"Minkoff","year":"2001","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.idc.2007.01.004_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-1702(02)00189-2","article-title":"Cervical and anal HPV infections in HIV positive women and men","volume":"89","author":"de Sanjose","year":"2002","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.idc.2007.01.004_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11904-005-0007-5","article-title":"Human papillomavirus-related cervical and anal disease in HIV-infected individuals in the era of highly active antiretroviral therapy","volume":"2","author":"Piketty","year":"2005","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"3","key":"10.1016\/j.idc.2007.01.004_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/318071","article-title":"Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women","volume":"183","author":"Palefsky","year":"2001","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2007.01.004_bib22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/jnci\/93.11.843","article-title":"Prevalence and risk factors for anal squamous intraepithelial lesions in women","volume":"93","author":"Holly","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.idc.2007.01.004_bib23","unstructured":"Kojic EM, Cu-Uvin S, Conley L, et\u00a0al. Human papilloma virus (HPV) infection of the anus is\u00a0more prevalent and diverse than HPV infection of the cervix among HIV-Infected Women in the SUN Study. Presented at the Infectious Disease Society of America 44th Annual Meeting. Toronto (Canada), October 12\u201315, 2006."},{"issue":"5","key":"10.1016\/j.idc.2007.01.004_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.idc.2007.01.004_bib25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00042560-199608150-00008","article-title":"Menstrual function in human immunodeficiency virus-infected women without acquired immunodeficiency syndrome","volume":"12","author":"Chirgwin","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"10","key":"10.1016\/j.idc.2007.01.004_bib26","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1086\/323999","article-title":"Frequency of anovulation and early menopause among women enrolled in selected adult AIDS clinical trials group studies","volume":"184","author":"Clark","year":"2001","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2007.01.004_bib27","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/0029-7844(96)00047-6","article-title":"Characteristics of menstruation in women infected with human immunodeficiency virus","volume":"87","author":"Ellerbrock","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00126334-200005010-00012","article-title":"Effect of HIV infection on menstrual cycle length","volume":"24","author":"Harlow","year":"2000","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.idc.2007.01.004_bib29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1067\/mob.2003.209","article-title":"Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virus","volume":"188","author":"Harlow","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.idc.2007.01.004_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/jwh.2006.15.591","article-title":"Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women","volume":"15","author":"Massad","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"issue":"12","key":"10.1016\/j.idc.2007.01.004_bib31","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2165\/00002018-200528120-00003","article-title":"Sex differences in antiretroviral therapy-associated intolerance and adverse events","volume":"28","author":"Clark","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.idc.2007.01.004_bib32","unstructured":"Cohn SE, Watts DH, Lertora J, et\u00a0al. An open-label, non-randomized study of the effect of depo-medroxyprogesterone acetate on the pharmacokinetics (PK) of selected protease inhibitors and non-nucleoside reverse transcriptase inhibitors therapies among HIV-infected women. Presented at the 12th Conference on Retroviruses and Opportunistic Infections. Hynes Convection Center, Boston (MA), February 22\u201325, 2005."},{"issue":"8","key":"10.1016\/j.idc.2007.01.004_bib33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0306-5456(00)00204-7","article-title":"Is the intrauterine device appropriate contraception for HIV-1-infected women?","volume":"108","author":"Morrison","year":"2001","journal-title":"BJOG"},{"issue":"15","key":"10.1016\/j.idc.2007.01.004_bib34","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1097\/00002030-199910220-00012","article-title":"Effect of intrauterine device use on cervical shedding of HIV-1 DNA","volume":"13","author":"Richardson","year":"1999","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0015-0282(16)56455-3","article-title":"Health during prolonged use of levonorgestrel 20 micrograms\/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR)","volume":"61","author":"Sivin","year":"1994","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.idc.2007.01.004_bib36","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00126334-200204150-00009","article-title":"Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission","volume":"29","author":"Cooper","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.idc.2007.01.004_bib37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2307\/2673717","article-title":"Fertility desires and intentions of HIV-positive men and women","volume":"33","author":"Chen","year":"2001","journal-title":"Fam Plann Perspect"},{"issue":"2","key":"10.1016\/j.idc.2007.01.004_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0029-7844(95)00399-1","article-title":"Pregnancy rates among women infected with human immunodeficiency virus. Adult\/Adolescent HIV Spectrum of Disease Project Group","volume":"87","author":"Chu","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.idc.2007.01.004_bib39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00002030-200401230-00018","article-title":"Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV","volume":"18","author":"Massad","year":"2004","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.idc.2007.01.004_bib40","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-3156.2005.01554.x","article-title":"Differences in fertility by HIV serostatus and adjusted HIV prevalence data from an antenatal clinic in northern Uganda","volume":"11","author":"Fabiani","year":"2006","journal-title":"Trop Med Int Health"},{"issue":"5","key":"10.1016\/j.idc.2007.01.004_bib41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00002030-200403260-00012","article-title":"HIV-1 disease progression and fertility: the incidence of recognized pregnancy and pregnancy outcome in Uganda","volume":"18","author":"Ross","year":"2004","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.idc.2007.01.004_bib42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.qai.0000148529.58963.83","article-title":"HIV-1 disease progression and fertility in Dar es Salaam, Tanzania","volume":"39","author":"Sedgh","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"14","key":"10.1016\/j.idc.2007.01.004_bib43","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/00002030-199612000-00013","article-title":"The effect of HIV diagnosis on reproductive experience. Study Group for the Medical Research Council Collaborative Study of Women with HIV","volume":"10","author":"Stephenson","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2007.01.004_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1651-2227.1997.tb18311.x","article-title":"Interaction between timing of perinatal human immunodeficiency virus infection and the design of preventive and therapeutic interventions","volume":"421","author":"Mofenson","year":"1997","journal-title":"Acta Paediatr Suppl"},{"issue":"12","key":"10.1016\/j.idc.2007.01.004_bib45","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1086\/420834","article-title":"Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis","volume":"189","author":"Coutsoudis","year":"2004","journal-title":"J Infect Dis"},{"issue":"9114","key":"10.1016\/j.idc.2007.01.004_bib46","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0140-6736(98)04197-X","article-title":"Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania","volume":"351","author":"Fawzi","year":"1998","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.idc.2007.01.004_bib47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJM199908053410602","article-title":"Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group","volume":"341","author":"Garcia","year":"1999","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.idc.2007.01.004_bib48","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199606203342501","article-title":"Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study","volume":"334","author":"Landesman","year":"1996","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.idc.2007.01.004_bib49","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM199908053410601","article-title":"Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team","volume":"341","author":"Mofenson","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.idc.2007.01.004_bib50","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0002-9378(94)90127-9","article-title":"The role of obstetric interventions in the prevention of pediatric human immunodeficiency virus infection","volume":"171","author":"Minkoff","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.idc.2007.01.004_bib51","first-page":"637","article-title":"Update on vertical HIV transmission","volume":"43","author":"Groginsky","year":"1998","journal-title":"J Reprod Med"},{"issue":"4","key":"10.1016\/j.idc.2007.01.004_bib52","first-page":"xi","article-title":"HIV disease in pregnancy. Introduction","volume":"24","author":"Minkoff","year":"1997","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"2","key":"10.1016\/j.idc.2007.01.004_bib53","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/JCM.33.2.292-297.1995","article-title":"Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type 1 isolates","volume":"33","author":"Reinhardt","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00126334-200309010-00005","article-title":"Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy","volume":"34","author":"De Pasquale","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9378(96)70261-2","article-title":"Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women","volume":"175","author":"Rasheed","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"22","key":"10.1016\/j.idc.2007.01.004_bib56","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1001\/archinte.157.22.2585","article-title":"Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study Group","volume":"157","author":"Alliegro","year":"1997","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.idc.2007.01.004_bib57","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1471-0528.1998.tb10226.x","article-title":"The effect of pregnancy on survival in women infected with HIV: a systematic review of the literature and meta-analysis","volume":"105","author":"French","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.idc.2007.01.004_bib58","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1067\/S0002-9378(03)00467-8","article-title":"The relationship of pregnancy to human immunodeficiency virus disease progression","volume":"189","author":"Minkoff","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.idc.2007.01.004_bib59","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nm0597-549","article-title":"Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant","volume":"3","author":"Cao","year":"1997","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.idc.2007.01.004_bib60","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00126334-200308150-00006","article-title":"Progression of HIV disease among women following delivery","volume":"33","author":"Watts","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"18","key":"10.1016\/j.idc.2007.01.004_bib61","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2007.01.004_bib62","unstructured":"Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States - October 12, 2006. Available at: http:\/\/aidsinfo.nih.gov. Accessed November 14, 2006."},{"key":"10.1016\/j.idc.2007.01.004_bib63","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(02)08214-4","article-title":"Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial","volume":"359","author":"Petra Study","year":"2002","journal-title":"Lancet"},{"issue":"9155","key":"10.1016\/j.idc.2007.01.004_bib64","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(98)10411-7","article-title":"Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group","volume":"353","author":"Shaffer","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.idc.2007.01.004_bib65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00126334-200302010-00006","article-title":"Nonnucleoside reverse transcriptase inhibitor resistance among antiretroviral-naive HIV-positive pregnant women","volume":"32","author":"Juethner","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"10.1016\/j.idc.2007.01.004_bib66","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1086\/323804","article-title":"Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades","volume":"184","author":"Palumbo","year":"2001","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib67","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1086\/430764","article-title":"Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP","volume":"192","author":"Eshleman","year":"2005","journal-title":"J\u00a0Infect Dis"},{"issue":"15","key":"10.1016\/j.idc.2007.01.004_bib68","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1097\/00002030-200110190-00006","article-title":"Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)","volume":"15","author":"Eshleman","year":"2001","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/430741","article-title":"Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated","volume":"192","author":"Johnson","year":"2005","journal-title":"J Infect Dis"},{"issue":"13","key":"10.1016\/j.idc.2007.01.004_bib70","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199904013401301","article-title":"The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1\u2013a meta-analysis of 15 prospective cohort studies","volume":"340","year":"1999","journal-title":"N Engl J Med"},{"issue":"9158","key":"10.1016\/j.idc.2007.01.004_bib71","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(98)08084-2","article-title":"Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. The European Mode of Delivery Collaboration","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.idc.2007.01.004_bib72","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1097\/00002030-200012220-00013","article-title":"The European Collaborative Study and the Swiss Mother Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy","volume":"14","year":"2000","journal-title":"AIDS"},{"issue":"24","key":"10.1016\/j.idc.2007.01.004_bib73","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa991159","article-title":"Antiretroviral therapy during pregnancy and the risk of an adverse outcome","volume":"346","author":"Tuomala","year":"2002","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.idc.2007.01.004_bib74","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/00002030-200308150-00006","article-title":"Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort","volume":"17","author":"Barret","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2007.01.004_bib75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00126334-200011010-00009","article-title":"Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts","volume":"25","author":"The Perinatal Safety Review Working Group","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.idc.2007.01.004_bib76","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/archinte.162.3.355","article-title":"Periconceptional exposure to efavirenz and neural tube defects","volume":"162","author":"De Santis","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2007.01.004_bib77","unstructured":"Available at: http:\/\/www.apregistry.com\/."},{"issue":"3","key":"10.1016\/j.idc.2007.01.004_bib78","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00126334-200407010-00002","article-title":"Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022","volume":"36","author":"Hitti","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.idc.2007.01.004_bib79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1468-1293.2006.00369.x","article-title":"Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy","volume":"7","author":"Lyons","year":"2006","journal-title":"HIV Med"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2007.01.004_bib80","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00126334-200309011-00005","article-title":"A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients","volume":"34","author":"Stern","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.idc.2007.01.004_bib81","unstructured":"Available at: http:\/\/www.fda.gov\/medWatch\/SAFETY\/2001\/pregwarnfinalBMS.pdf."},{"issue":"6","key":"10.1016\/j.idc.2007.01.004_bib82","first-page":"41","article-title":"Metabolic complications of antiretroviral therapies","volume":"10","author":"Dube","year":"1998","journal-title":"AIDS Clin Care"},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib83","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.aids.0000198090.70325.bd","article-title":"Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy","volume":"20","author":"Suy","year":"2006","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.idc.2007.01.004_bib84","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/01.CIR.0000054674.89019.1A","article-title":"Review of the international position paper on women's health and menopause: a comprehensive approach","volume":"107","author":"Paoletti","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.idc.2007.01.004_bib85","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00002030-200204120-00012","article-title":"The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women","volume":"16","author":"van Benthem","year":"2002","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.idc.2007.01.004_bib86","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1086\/375372","article-title":"Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes","volume":"187","author":"Kalayjian","year":"2003","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2007.01.004_bib87","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/319678","article-title":"Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study","volume":"183","author":"Viard","year":"2001","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib88","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00126334-200305010-00016","article-title":"Antiretroviral treatment and advanced age: epidemiologic, laboratory, and clinical features in the elderly","volume":"33","author":"Manfredi","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib89","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00002030-200301030-00020","article-title":"Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario","volume":"17","author":"Tumbarello","year":"2003","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib90","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1385\/ENDO:12:1:81","article-title":"Influence of estrogen deficiency and replacement on T-cell populations in rat lymphoid tissues and organs","volume":"12","author":"Safadi","year":"2000","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.idc.2007.01.004_bib91","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/0003-4819-103-3-350","article-title":"Smoking and age at menopause in women","volume":"103","author":"McKinlay","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2007.01.004_bib92","unstructured":"Cejtin H, Kim S, Taylor T, et\u00a0al. Menopause in women in the Women's Interagency HIV Study (WIHS). Presented at the XV International AIDS Conference. Bangkok (Thailand), July 11\u201316, 2004."},{"issue":"10","key":"10.1016\/j.idc.2007.01.004_bib93","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1086\/497270","article-title":"HIV infection, drug use, and onset of natural menopause","volume":"41","author":"Schoenbaum","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2007.01.004_bib94","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/01.ede.0000134868.53468.b7","article-title":"Current smoking at menopause rather than duration determines the onset of natural menopause","volume":"15","author":"van Asselt","year":"2004","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.idc.2007.01.004_bib95","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1086\/314027","article-title":"Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy","volume":"31","author":"Wanke","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2007.01.004_bib96","unstructured":"Cejtin H, Kim S, Taylor T, et\u00a0al. Assessment of menopausal status among women in the Women's Interagency HIV Study (WIHS). Presented at the XV International AIDS Conference. Bangkok (Thailand), July 11\u201316, 2004."},{"issue":"1","key":"10.1016\/j.idc.2007.01.004_bib97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00042560-200001010-00016","article-title":"Perimenopausal symptomatology among HIV-infected women at least 40 years of age","volume":"23","author":"Clark","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.idc.2007.01.004_bib98","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00006842-200107000-00013","article-title":"Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife","volume":"63","author":"Bosworth","year":"2001","journal-title":"Psychosom Med"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552007000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552007000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T01:06:21Z","timestamp":1587517581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552007000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0891552007000062"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2007.01.004","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}